Mazor Robotics shareholders approve US$1.64B Medtronic transaction


Mazor Robotics has announced that at a Special General Meeting of Shareholders held on 19 November, 2018, Mazor shareholders approved the previously announced definitive merger agreement with wholly-owned subsidiaries of Medtronic.

Approximately 53% of Mazor Robotics ordinary shares were represented in the meeting. Approximately 95% of the shares represented in the meeting which are neither held by a Medtronic affiliated party nor by a controlling shareholder of the Company or a shareholder with a personal interest in the merger proposal, were cast in favour of the merger.

Upon completion of the transaction, Mazor Robotics shareholders will receive US$58.50 per American Depository Share, or US$29.25 per ordinary share, in cash, for a total of approximately US$1.64 billion. The transaction remains subject to certain closing conditions and is expected to close during Medtronic’s third fiscal quarter ending 25 January, 2019.


Please enter your comment!
Please enter your name here